A recent study led by Monash University and Alfred Health at the Melbourne Sexual Health Centre has identified bacterial vaginosis (BV) as a sexually transmitted infection (STI), prompting a significant re-evaluation of treatment methods. Affecting almost a third of women globally, BV has been linked to serious health risks, including infertility, premature births, and newborn fatalities.
Published in the New England Journal of Medicine, the research revealed that traditional treatments, which address BV as an imbalance in the vaginal microbiome, have proven insufficient. Over 50% of women experience a recurrence of the infection within three months after receiving standard antibiotic therapy lasting a week. Conversely, the study involved 164 couples in monogamous relationships and demonstrated notably improved outcomes when both partners were treated simultaneously, reinforcing the STI classification of BV.
Professor Catriona Bradshaw, a co-author of the study, described the new treatment approach as cost-effective and brief, suggesting it holds promise for enhancing health outcomes for women. Following these findings, the Melbourne Sexual Health Centre has updated its clinical protocols to treat couples rather than individuals.
In anticipation of updated treatment guidelines, a dedicated website has been launched for both health professionals and the public. This initiative aims to facilitate the prescription and acquisition of partner treatment information, designed collaboratively with input from consumers and trial participants. Professor Bradshaw emphasised the importance of making accurate resources readily available as the new findings emerge.
Assistant Minister for Health, Aged Care, and Indigenous Health, Ged Kearney, highlighted the potential impact of this research, noting that a straightforward adjustment in treatment strategies could significantly benefit women. Kearney remarked on the serious implications of BV, which can lead to complications like early pregnancy loss and premature labour, underscoring the need for more effective treatment options.
Overall, this groundbreaking study signifies a shift in the understanding of BV, advocating for comprehensive treatment approaches that include both partners to mitigate the recurrence of the infection and improve women’s health outcomes.